| 查看: 363 | 回复: 0 | |||
[交流]
【求助/交流】有荧光标记的多肽在进行低聚物处理后荧光淬灭?
|
|
实验步骤如下,是参考国外文献的: •Solid A peptide was dissolved in cold hexafluoro-2-propanol (HFIP). •The peptide was incubated at room temperature for at least 1 h to establish monomerization and randomization of structure. •The HFIP was removed by evaporation, and the resulting peptide was stored as a film at -20 or -80 °C. •The resulting film was dissolved in anhydrous DMSO at 5 mM and then diluted into the appropriate concentration and buffer with vortexing. •Next, the solution was aged 24 h at 4-8 °C. The sample was then centrifuged at 14000g for 10 min at 4-8 °C; the soluble oligomers were in the supernatant. •Usually, a small pellet was observed suggesting there was some pelletable material in 24 h aggregations. 我照着做了,但是溶入F12以后就形成了絮状物(红色的,因为标记了荧光)。但是放置冰箱的过程中,红色就不见了,絮状物也不见了。为什么呀?离心完就只剩下一点点颜色很浅的沉淀物了。 大家帮忙出出主意吧,谢谢啦 |
» 猜你喜欢
HILIC磁珠研究蛋白组学怎么做?
已经有0人回复
His标签蛋白纯化怎么才能快?
已经有0人回复
化学工程及工业化学论文润色/翻译怎么收费?
已经有252人回复
WRN变构抑制剂HRO761:从D1/D2界面锁定到MSI合成致死的工具化合物深度解析
已经有0人回复
KRAS G12V(ON) 选择性抑制剂 RMC-5127:从三元复合物机制到科研应用
已经有0人回复
SHP2 变构抑制剂 Sitneprotafib:从作用机制到科研试剂选型要点
已经有0人回复
PRMT5·MTA 抑制剂 MRTX1719 的科研应用
已经有0人回复
SW033291 科研使用解析:分子特征、储存与实验获取要点
已经有0人回复
泛 RAS 抑制新思路:大环肽拟似物如何同时牵住突变型与野生型 RAS?
已经有0人回复
TYK2/JAK1 双靶点工具化合物 Brepocitinib:激酶选择性、研究进展与实验应用全解析
已经有0人回复
矢车菊素-3-O-葡萄糖苷质控实录:从一张HPLC图谱读懂纯度与稳定性
已经有0人回复










回复此楼